Advanced Enzyme Technologies Ltd

Thu 27/08/2026,15:58:53 | NSE : ADVENZYMES

₹297.600.40 (0.13%)

Data is delayed. Analysis is best done in real-time! Open a FREE Sharekhan Demat A/c in 15 mins* and continue your analysis with real-time data.

Market Data

Essential tool: analyze, trade, manage, decide.

Open

₹ 297.80

Previous Close

₹ 297.20

Volume

202752

Mkt Cap ( ₹ Cr)

₹ 3332.41

High

₹ 300.65

Low

₹ 295.70

52 Week High

₹ 419.00

52 Week Low

₹ 251.95

Book Value Per Share

₹ 149.19

Dividend Yield

1.75

Face Value

₹ 2.00

What's Your Call?

Collective community sentiment on Advanced Enzyme Technologies Ltd

Your Vote -

Buy

94.34%

Hold

0.98%

Sell

4.69%

94.34%

1024 users have voted

Market Depth

How many stocks are available to buy or sell and at what prices.

Buy Order Quantity

100%

Sell Order Quantity

0%

Bid Price

Qty

297.60

27

0.00

0

0.00

0

0.00

0

0.00

0

Bid Total

27

Bid Price

Qty

0.00

0

0.00

0

0.00

0

0.00

0

0.00

0

Bid Total

0

Option Chain

Analyzes market sentiment, predicts Advanced Enzyme Technologies Ltd' movement.

NO_RECORD_FOUND

News

Media spotlight triggers stock stock attention, sentiment.

  • Advanced Enzyme Tech - Announcement under Regulation 30 (LODR)-Daily Buy Back of equity shares

    27 Aug 2026, 6:31PM Daily Report pursuant to Regulation 18(i) of the Buyback Regulations regarding the Equity Shares bought back on August 27, 2026.
  • Advanced Enzyme Tech - Announcement under Regulation 30 (LODR)-Daily Buy Back of equity shares

    25 Aug 2026, 6:22PM Daily Report pursuant to Regulation 18(i) of the Buyback Regulations regarding the Equity Shares bought back on August 25, 2026.
  • Advanced Enzyme Tech - Announcement under Regulation 30 (LODR)-Daily Buy Back of equity shares

    24 Aug 2026, 6:01PM Daily Report pursuant to Regulation 18(i) of the Buyback Regulations regarding the Equity Shares bought back on August 24, 2026.
  • Advanced Enzyme Tech Q1 net profit down 69.79% at Rs 22.35 cr

    22 Aug 2026, 7:50PM The company reported standalone net profit of Rs 22.35 crore for the quarter ended June 30, 2026 as compared to Rs 73.98 crore in the same period last
  • Advanced Enzyme Tech - Announcement under Regulation 30 (LODR)-Daily Buy Back of equity shares

    21 Aug 2026, 5:49PM Daily Report pursuant to Regulation 18(i) of the Buyback Regulations regarding the Equity Shares bought back on August 21, 2026.
  • Advanced Enzyme Tech - Announcement under Regulation 30 (LODR)-Daily Buy Back of equity shares

    20 Aug 2026, 6:10PM Daily Report pursuant to Regulation 18(i) of the Buyback Regulations regarding the Equity Shares bought back on August 20, 2026
  • Advanced Enzyme Tech - Announcement under Regulation 30 (LODR)-Daily Buy Back of equity shares

    19 Aug 2026, 6:33PM Daily Report pursuant to Regulation 18(i) of the Buyback Regulations regarding the Equity Shares bought back on August 19, 2026
  • Advanced Enzyme Tech - Analysts/Institutional Investor Meet/Con. Call Updates

    18 Aug 2026, 6:00PM Advanced Enzyme Technologies Limited has informed the Exchange about Transcript
  • Advanced Enzyme Tech - Announcement under Regulation 30 (LODR)-Earnings Call Transcript

    18 Aug 2026, 5:53PM Transcript of Conference Call held on August 12, 2026 for the Unaudited Financial Results for the Quarter ended June 30, 2026
  • Advanced Enzyme Tech - Announcement under Regulation 30 (LODR)-Daily Buy Back of equity shares

    18 Aug 2026, 5:43PM Daily Report pursuant to Regulation 18(i) of the Buyback Regulations regarding the Equity Shares bought back on August 18, 2026
  • Advanced Enzyme Tech - Announcement under Regulation 30 (LODR)-Daily Buy Back of equity shares

    17 Aug 2026, 9:40PM Daily Report pursuant to Regulation 18(i) of the Buyback Regulations regarding the Equity Shares bought back on August 17, 2026
  • Advanced Enzyme Tech - Announcement under Regulation 30 (LODR)-Daily Buy Back of equity shares

    17 Aug 2026, 9:36PM Daily Report pursuant to Regulation 18(i) of the Buyback Regulations regarding the Equity Shares bought back on August 14, 2026
  • Advanced Enzyme Tech - General Updates

    13 Aug 2026, 4:45PM Advanced Enzyme Technologies Limited has informed the Exchange about General Updates
  • Advanced Enzyme Tech - Analysts/Institutional Investor Meet/Con. Call Updates

    12 Aug 2026, 9:15PM Advanced Enzyme Technologies Limited has informed the Exchange about Link of Recording
  • Advanced Enzyme Tech - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome

    12 Aug 2026, 9:09PM Please find enclosed herewith audio recording of earnings call held on August 12, 2026.
  • Advanced Enzyme Tech - Corporate Action-Updates on Buy back

    11 Aug 2026, 6:27PM Bord Resolution for the Buyback
  • Advanced Enzyme Tech - Buyback

    11 Aug 2026, 6:22PM Advanced Enzyme Technologies Limited has submitted the Exchange the Board Resolution of Buyback
  • Advanced Enzyme Tech - Announcement under Regulation 30 (LODR)-Public Announcement-Buyback of Shares

    11 Aug 2026, 6:19PM Public Announcement - BuyBack of the Equity Shares
  • Advanced Enzyme Tech - Public Announcement - Buyback of Shares

    11 Aug 2026, 6:18PM Advanced Enzyme Technologies Limited has informed the Exchange about public Announcement - Buyback of Shares
  • Advanced Enzyme Tech - Copy of Newspaper Publication

    10 Aug 2026, 5:15PM Advanced Enzyme Technologies Limited has informed the Exchange about Copy of Newspaper Publication
  • Advanced Enzyme Tech - Investor Presentation

    8 Aug 2026, 5:23PM Advanced Enzyme Technologies Limited has informed the Exchange about Investor Presentation
  • Advanced Enzyme Tech - Press Release

    8 Aug 2026, 5:20PM Advanced Enzyme Technologies Limited has informed the Exchange regarding a press release dated August 08, 2026, titled ""Quarterly Earnings Release"".
  • Advanced Enzyme Tech - Acquisition

    8 Aug 2026, 1:38PM Advanced Enzyme Technologies Limited has informed the Exchange about Acquisition
  • Advanced Enzyme Tech - Outcome of Board Meeting

    8 Aug 2026, 1:36PM Advanced Enzyme Technologies Limited has informed the Exchange regarding Outcome of Board Meeting held on August 08, 2026.
  • Advanced Enzyme Tech - Outcome of Board Meeting

    8 Aug 2026, 1:31PM Advanced Enzyme Technologies Limited has submitted to the Exchange, the financial results for the period ended Jun 30, 2026.
  • Advanced Enzyme Tech - Announcement under Regulation 30 (LODR)-Press Release / Media Release

    8 Aug 2026, 5:30PM Press Release titled Quaterly Earnings Release dated August 08, 2026
  • Advanced Enzyme Tech - Announcement under Regulation 30 (LODR)-Investor Presentation

    8 Aug 2026, 5:24PM Earnings Presentation for the Quarter ended June 30, 2026
  • Advanced Enzyme Tech - Corporate Action-Buy back

    8 Aug 2026, 1:56PM Approved the Buy-Back of fully paid-up of Equity Shares of the Company via Open Market through Stock Exchanges
  • Advanced Enzyme Tech - Announcement under Regulation 30 (LODR)-Acquisition

    8 Aug 2026, 1:47PM 1) Approved acquistion of the remaining stake of 4.28% Equity Shares from the other existing Equity Shareholders of JC Biotech Private Limited (Exisit
  • Advanced Enzyme Tech - Unaudited Financial Results For The Quarter Ended June 30, 2026

    8 Aug 2026, 1:33PM Un-audited Financial Results for the Quarter ended June 30, 2026
  • Advanced Enzyme Tech - Board Meeting Outcome for Outcome Of Board Meeting Held On August 08, 2026

    8 Aug 2026, 1:25PM 1) Approved the Un-audited Financial Results (Standalone and Consolidated) of the Company for the quarter ended June 30, 2026\r\n2)Approved the Buybac
  • Advanced Enzyme Tech - Analysts/Institutional Investor Meet/Con. Call Updates

    4 Aug 2026, 3:07PM Advanced Enzyme Technologies Limited has informed the Exchange about Schedule of meet
  • Advanced Enzyme Tech - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

    4 Aug 2026, 3:01PM Pursuant to Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 (as amende
  • Advanced Enzyme Tech - General Updates

    1 Aug 2026, 4:03PM Advanced Enzyme Technologies Limited has informed the Exchange about General Updates
  • Advanced Enzyme Tech - Shareholders meeting

    1 Aug 2026, 3:53PM Advanced Enzyme Technologies Limited has submitted the Exchange a copy Srutinizers report of Annual General Meeting held on July 31, 2026. Further, t
  • Advanced Enzyme Tech - Shareholder Meeting / Postal Ballot-Scrutinizer's Report

    1 Aug 2026, 3:53PM Scrutinizer Report and Voting Results - 37th Annual General Meeting
  • Advanced Enzyme Tech - Shareholder Meeting / Postal Ballot-Scrutinizer's Report

    1 Aug 2026, 3:53PM Scrutinizer Report and Voting Results - 37th Annual General Meeting
  • Advanced Enzyme Tech - Intimation Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulati

    1 Aug 2026, 4:08PM 1) Re-appointment of Mr. Mukund Madhusudan Kabra \r\n(DIN-00148294) as whole-Time Director of the Company for another term of five years effective fro
  • Advanced Enzyme Tech - Shareholder Meeting / Postal Ballot-Scrutinizer's Report

    1 Aug 2026, 3:53PM Scrutinizer Report and Voting Results - 37th Annual General Meeting
  • Advanced Enzyme Tech - Board Meeting Intimation for Consideration And Approval Of Unaudited Financial Results For Quarter End

    1 Aug 2026, 12:50PM Advanced Enzyme Technologies Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 08/08/2026 ,inter alia, to
  • Advanced Enzyme Tech - Shareholders meeting

    31 Jul 2026, 6:48PM Advanced Enzyme Technologies Limited has informed the Exchange regarding Proceedings of Annual General Meeting held on July 31, 2026
  • Advanced Enzyme Tech - Shareholder Meeting / Postal Ballot-Outcome of AGM

    31 Jul 2026, 6:43PM Proceeding of 37th Annual General Meeting (AGM) held on July 31, 2026
  • Advanced Enzyme Tech - Shareholder Meeting / Postal Ballot-Scrutinizer's Report

    1 Aug 2026, 3:53PM Scrutinizer Report and Voting Results - 37th Annual General Meeting
  • Advanced Enzyme Tech has submitted to BSE the Shareholding Pattern for the Period Ended June 30, 2026

    18 Jul 2026, 7:20PM As of June 2026, 43.24% is owned by Promoters and 56.76% by Public. <p align=justify> Among Promoters holding, Indian Promoters holds 1.95% and Foreig
  • Advanced Enzyme Tech - Certificate under SEBI (Depositories and Participants) Regulations, 2018

    14 Jul 2026, 4:45PM Advanced Enzyme Technologies Limited has informed the Exchange about Certificate under SEBI (Depositories and Participants) Regulations, 2018
  • Advanced Enzyme Tech - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

    14 Jul 2026, 4:41PM Certificate under Regulation 74(5) of the Securities and Exchange Board of India (Depositories and Participants) Regulations, 2018 - for the Quarter e
  • Advanced Enzyme Tech - Copy of Newspaper Publication

    9 Jul 2026, 3:29PM Advanced Enzyme Technologies Limited has informed the Exchange about Copy of Newspaper Publication
  • Advanced Enzyme Tech - General Updates

    8 Jul 2026, 4:49PM Advanced Enzyme Technologies Limited has informed the Exchange regarding copy of letter sent to those shareholders who have not registered their e-mai
  • Advanced Enzyme Tech - General Updates

    8 Jul 2026, 4:34PM Advanced Enzyme Technologies Limited has informed the Exchange about Business Responsibility and Sustainability Report for the Financial Year 2025-26.
  • Advanced Enzyme Tech - Shareholders meeting

    8 Jul 2026, 4:21PM Advanced Enzyme Technologies Limited has informed the Exchange regarding Notice of Annual General Meeting to be held on July 31, 2026
  • Advanced Enzyme Tech - Copy Of Letter Sent To The Shareholders Pursuant To Regulation 36(1)(B) Of SEBI (LODR) Regulations, 20

    8 Jul 2026, 4:51PM Copy of letter to Shareholders - Pursuant to Regulation 36(1)(b) of SEBI (LODR) Regulations, 2015
  • Advanced Enzyme Tech - Business Responsibility and Sustainability Reporting (BRSR)

    8 Jul 2026, 4:41PM Business Responsibility and Sustainability Report for the financial year 2025-2026
  • Advanced Enzyme Tech - Reg. 34 (1) Annual Report.

    8 Jul 2026, 4:37PM Integrated Annual Report for FY 2025-2026
  • Advanced Enzyme Tech - Notice Of The 37Th Annual General Meeting Of The Company

    8 Jul 2026, 4:25PM Notice convening 37th Annual General Meeting of the Company scheduled to be held on Friday, July 31, 2026 at 10.00 a.m. (IST) through Video Conference
  • Advanced Enzyme Tech has declared 67.50% Final dividend for the financial year March 2026

    7 Jul 2026, 10:50AM Advanced Enzyme Technologies Ltd. on Monday, 11 May 2026, has announced Final dividend of 67.50 percent on Equity Share, to its shareholders holding s
  • Advanced Enzyme Tech - Copy of Newspaper Publication

    4 Jul 2026, 3:16PM Advanced Enzyme Technologies Limited has informed the Exchange about Copy of Newspaper Publication
  • Advanced Enzyme Tech - General Updates

    3 Jul 2026, 6:47PM Advanced Enzyme Technologies Limited has informed the Exchange about the date of the 37th Annual general Meeting of the Company.
  • Advanced Enzyme Tech - Record Date

    3 Jul 2026, 6:42PM Advanced Enzyme Technologies Limited has informed the Exchange that Record date for the purpose of Dividend is 24-Jul-2026.
  • Advanced Enzyme Tech - Intimation Of The Date Of 37Th Annual General Meeting

    3 Jul 2026, 6:36PM Please find enclosed herewith the intimation regarding the date of the 37th Annual general Meeting.
  • Advanced Enzyme Tech - Record Date For Payment Of Final Dividend

    3 Jul 2026, 6:31PM Please find enclosed herewith the intimation of record date for payment of final dividend.
  • Advanced Enzyme Tech - Trading Window

    25 Jun 2026, 2:50PM Advanced Enzyme Technologies Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading)
  • Advanced Enzyme Tech - Copy of Newspaper Publication

    12 Jun 2026, 5:02PM Advanced Enzyme Technologies Limited has informed the Exchange about Copy of Newspaper Publication
  • Advanced Enzyme Tech - Disclosure under SEBI Takeover Regulations

    12 Jun 2026, 12:11PM Chandrakumar Laxminarayan Rathiÿhas Submitted to the Exchange a copy of Disclosure under Regulation 31(4) of the Securities and Exchange Board of Indi
  • Advanced Enzyme Tech - Change in Director(s)

    11 Jun 2026, 4:18PM Advanced Enzyme Technologies Limited has informed the Exchange regarding Change in Director(s) of the company.
  • Advanced Enzyme Tech - Announcement under Regulation 30 (LODR)-Change in Directorate

    11 Jun 2026, 4:11PM Please find enclosed herewith intimation regarding completion of second term of Ms. Rajshree Patel as Independent Director of the Company.
  • Advanced Enzyme Tech - Acquisition

    6 Jun 2026, 8:44PM Further to the intimation letter dated August 02, 2025, we hereby inform that the Companyhas completed an additional investment of &#8377; 2.5 million
  • Advanced Enzyme Tech - Announcement under Regulation 30 (LODR)-Updates on Acquisition

    6 Jun 2026, 8:17PM Please find enclosed herewith the update regarding the additional investment in wholly owned subsidiary of the Company - Advanced Nutrazyme Private Li
  • Advanced Enzyme Tech - Disclosure under SEBI Takeover Regulations

    5 Jun 2026, 6:01PM Vasant L. Rathi has Submitted to the Exchange a copy of Disclosure under Regulation 31(4) of the Securities and Exchange Board of India (Substantial A
  • Advanced Enzymes announces positive clinical breakthrough

    13 Sep 2021 , 12:08PM Advanced Enzymes announces positive clinical breakthrough in the randomised controlled trials of systemic enzymes & probiotics to resolve 'long COVID’ fatigue symptoms
  • Advanced Enzymes

    19 Oct 2020 , 10:57AM Advanced Enzymes: CRISIL has upgraded long term credit rating of Advanced Enzymes to “CRISIL A+/Stable” from “CRISIL A/Stable” earlier and has reaffirmed short term credit rating at CRISIL A1.
  • Advanced Enzyme hits 52-week high

    17 Sep 2020 , 12:21PM Advanced Enzyme rises by 5% to Rs. 243.30 in weak market

Key fundamentals

Evaluate the intrinsic value of Advanced Enzyme Technologies Ltd stock 

Name March-26 March-25 March-24 March-23 March-22
Assets 709.623 629.341 580.471 525.339 480.528
Liabilities 709.623 629.341 580.471 525.339 480.528
Equity 22.385 22.376 22.365 22.365 22.36
Gross Profit 110.434 70.679 105.186 74.888 72.648
Net Profit 131.806 102.42 108.123 55.527 54.511
Cash From Operating Activities 88.731 63.479 55.81 50.296 37.102
NPM(%) 29.11 29.14 29.58 17.82 19.98
Revenue 452.766 351.411 365.469 311.529 272.798
Expenses 342.332 280.732 260.283 236.641 200.15
ROE(%) 7.88 6.13 6.47 3.32 3.26

Shareholding Pattern

Corporate Action

XD-Date Dividend-Amount Dividend-% Dividend Yield(%GE) Price on that day
24 Jul 2026 1.35 67.5 1.75 390.4
16 May 2025 4 200 1.75 283.7
23 Jul 2025 1.2 60 1.75 279.05
18 Jul 2024 1.1 55 1.75 398.65
04 Aug 2023 1 50 1.75 284.65
11 Aug 2022 1 50 1.75 277.85
31 Aug 2021 0.9 45 1.75 427.85
09 Jul 2020 0.6 30 1.75 149.9
01 Aug 2019 0.6 30 1.75 200.85
06 Sep 2018 0.5 25 1.75 221.4
04 Sep 2017 0.4 20 1.75 362.4

Peers

Other companies within the same industry or sector that are comparable to Advanced Enzyme Technologies Ltd

Company Price Price (% change) pe(x) EV/EBITDA(x) ROE(%) ROCE(%)
Sameera Agro And Infra Ltd 5.00 -0.99 2.05 353.66 24.38 0.00
Shreeoswal Seeds and Chemicals Ltd 12.17 -1.62 9.08 2716.20 39.48 0.00
GRM Overseas Ltd 87.76 -1.22 23.78 1781.70 179.39 0.00
Jain Irrigation Systems Ltd 29.69 -1.26 0.00 21793.16 -17.22 0.00

Company Info

The Company was incorporated, as a private limited company on March 15, 1989 under the provisions of the Companies Act, 1956 as Advanced Biochemicals Private Limited in Maharashtra. Pursuant to a special resolution passed by the shareholders of the Company at the extra-ordinary general meeting held on April 21, 1992, the Company was converted into a public limited company and consequently the name of the Company was changed to Advanced Biochemicals Limited. A fresh certificate of incorporation reflecting the new name was issued by the Registrar of Companies, Maharashtra on May 28, 1992. Pursuant to a special resolution passed by the shareholders of the Company at the extraordinary general meeting held on August 8, 2005, the name of the Company was further changed from Advanced Biochemicals Limited to Advanced Enzyme Technologies Limited. A fresh certificate of incorporation reflecting the new name was issued by the Registrar of Companies, Maharashtra, Mumbai on August 19, 2005.  Major events in the History of the Company 1989 - Incorporation as Advanced Biochemicals Private Limited.  1992 - Conversion from private company into a public company and renamed as Advanced Biochemicals Limited. 1994 - Commissioning of the first fermentation facility at Sinnar, Maharashtra  2001 - Recognition of in-house R&D centers of the Company at Thane and Sinnar by the Department of Scientific and Industrial Research, Ministry of Science and Technology, Government of India.  2005 - Change of name of the Company from Advanced Biochemicals Limited to Advanced Enzyme Technologies Limited.  2011 - Takeover of Cal-India Foods International (Specialty Enzymes and Biotechnologies) by the Company giving us direct presence in USA.  2012 - Kotak India Venture Fund I, Kotak Employees Investment Trust and Kotak India Venture (Offshore) Fund made an investment in the Company.  2012 - Takeover of AST Enzymes by the Company for consolidating the presence in USA. Awards and accreditations received by the Company  2010 - The Company won the "Emerging India Awards" for 2010 in the Life Science -Pharmaceuticals & Chemicals segment organized by ICICI Business Banking and CNBC TV18.2010 - The Company won the Bio Excellence Award in the Industrial Biotech category for 2010 instituted by Department of Information Technology, Biotechnology and Science and Technology, Government of Karnataka.2012 - The Company was awarded as the 1st runner-up for the Most Innovative Exporter - Dun & Bradstreet for the year 2012.  2013 - The Company was one of the Recipients of the fastest growing mid-sized business award organized by Inc. India.  2014 - The Company received the Bio Excellence Award in the Industrial Biotech category for year 2014 instituted by Department of Information Technology, Biotechnology and Science and Technology,Government of Karnataka. 2016 -Advanced Enzyme Technologies are listed and admitted to dealings on the Exchange in the list of 'B' Group Securities. - "Advanced Enzymes acquires 70% stake in API maker JC Biotech". - Advanced Enzyme Technologies has been awarded by ABP News for being "The Best Nutraceutical Company of the Year". 2017 -The Company has been awarded for 'BEST IPO' at IR Society Awards 2017. -Acquired 100% stake in a German based company evoxx technologies GmbH. 2018 -Acquired 100% stake in SciTech Specialties Private Limited. 2023 -Advanced Enzyme Technologies Limited has informed the Exchange regarding 'Update on acquisition of 50% stake in Saiganesh Enzytech Solutions Private Limited;and an additional 4.83% of JC Biotech Private Limited. 2024 -Advanced Enzyme Technologies Limited has informed the acquisition of additional stake of 5.89% in JC Biotech Private Limited.

The Company was incorporated, as a private limited company on March 15, 1989 under the provisions of the Companies Act, 1956 as Advanced Biochemicals Private Limited in Maharashtra. Pursuant to a special resolution passed by the shareholders of the Company at the extra-ordinary general meeting held on April 21, 1992, the Company was converted into a public limited company and consequently the name of the Company was changed to Advanced Biochemicals Limited. A fresh certificate of incorporation reflecting the new name was issued by the Registrar of Companies, Maharashtra on May 28, 1992. Pursuant to a special resolution passed by the shareholders of the Company at the extraordinary general meeting held on August 8, 2005, the name of the Company was further changed from Advanced Biochemicals Limited to Advanced Enzyme Technologies Limited. A fresh certificate of incorporation reflecting the new name was issued by the Registrar of Companies, Maharashtra, Mumbai on August 19, 2005.  Major events in the History of the Company 1989 - Incorporation as Advanced Biochemicals Private Limited.  1992 - Conversion from private company into a public company and renamed as Advanced Biochemicals Limited. 1994 - Commissioning of the first fermentation facility at Sinnar, Maharashtra  2001 - Recognition of in-house R&D centers of the Company at Thane and Sinnar by the Department of Scientific and Industrial Research, Ministry of Science and Technology, Government of India.  2005 - Change of name of the Company from Advanced Biochemicals Limited to Advanced Enzyme Technologies Limited.  2011 - Takeover of Cal-India Foods International (Specialty Enzymes and Biotechnologies) by the Company giving us direct presence in USA.  2012 - Kotak India Venture Fund I, Kotak Employees Investment Trust and Kotak India Venture (Offshore) Fund made an investment in the Company.  2012 - Takeover of AST Enzymes by the Company for consolidating the presence in USA. Awards and accreditations received by the Company  2010 - The Company won the "Emerging India Awards" for 2010 in the Life Science -Pharmaceuticals & Chemicals segment organized by ICICI Business Banking and CNBC TV18.2010 - The Company won the Bio Excellence Award in the Industrial Biotech category for 2010 instituted by Department of Information Technology, Biotechnology and Science and Technology, Government of Karnataka.2012 - The Company was awarded as the 1st runner-up for the Most Innovative Exporter - Dun & Bradstreet for the year 2012.  2013 - The Company was one of the Recipients of the fastest growing mid-sized business award organized by Inc. India.  2014 - The Company received the Bio Excellence Award in the Industrial Biotech category for year 2014 instituted by Department of Information Technology, Biotechnology and Science and Technology,Government of Karnataka. 2016 -Advanced Enzyme Technologies are listed and admitted to dealings on the Exchange in the list of 'B' Group Securities. - "Advanced Enzymes acquires 70% stake in API maker JC Biotech". - Advanced Enzyme Technologies has been awarded by ABP News for being "The Best Nutraceutical Company of the Year". 2017 -The Company has been awarded for 'BEST IPO' at IR Society Awards 2017. -Acquired 100% stake in a German based company evoxx technologies GmbH. 2018 -Acquired 100% stake in SciTech Specialties Private Limited. 2023 -Advanced Enzyme Technologies Limited has informed the Exchange regarding 'Update on acquisition of 50% stake in Saiganesh Enzytech Solutions Private Limited;and an additional 4.83% of JC Biotech Private Limited. 2024 -Advanced Enzyme Technologies Limited has informed the acquisition of additional stake of 5.89% in JC Biotech Private Limited.

Parent Organisation

Advanced Enzyme Technologies Ltd.

Founded

15/03/1989

Managing Director

NSE Symbol

ADVENZYMESEQ

FAQ